Source document or public record
FDA 510(k) K221842 — Elecsys B-Amyloid (1-42) CSF II, Elecsys Phospho-Tau (181P) CSF
FDA 510(k) index record K221842. Device: Elecsys B-Amyloid (1-42) CSF II, Elecsys Phospho-Tau (181P) CSF. Applicant as listed: Roche Diagnostics. Decision date: 2022-12-07.
Source
"device_name": "Elecsys B-Amyloid (1-42) CSF II, Elecsys Phospho-Tau (181P) CSF"
This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.
Review and references
Automated FDA record verification
2026-10-20
2026-10-20
professional use
FDA 510(k) public index record K221842.
Device name: Elecsys B-Amyloid (1-42) CSF II, Elecsys Phospho-Tau (181P) CSF. Applicant as listed: Roche Diagnostics.
Decision date: 2022-12-07. Decision wording: Substantially Equivalent.
Product code: QSE. Regulation: 21 CFR 866.5840. Medical specialty: Immunology.
This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.
Interested in these solutions?
Submit a sourcing request with the assays, volumes, and timeline of your own project.